ELOXX PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Basic Shares Outstanding (Weighted Average) of 6.79 million shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.79M shares, a 1856.53% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.38M shares, a 1166.84% increase year-over-year.
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 347.00K shares.
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 345.96K shares.
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 2.17M shares, a 23.85% increase from fiscal 2021.
- ELOXX PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 1.75M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.79M shares S-1 · filed 2026-09-11 | 5.59M shares S-1 · filed 2026-09-11 | ||||||
| 2026-03-31 | 4.38M shares S-1/A · filed 2026-06-04 | 48.21M shares 10-Q · filed 2026-05-05 | ||||||
| 2025-12-31 | 1.12M shares S-1 · filed 2026-09-11 | 12.35M shares 10-K · filed 2026-03-17 | ||||||
| 2025-06-30 | 347.00K shares S-1 · filed 2026-09-11 | 346.48K shares S-1 · filed 2026-09-11 | ||||||
| 2025-03-31 | 345.96K shares S-1/A · filed 2026-06-04 | 3.81M shares 10-Q · filed 2026-05-05 | ||||||
| 2024-12-31 | 341.71K shares S-1 · filed 2026-09-11 | 3.76M shares 10-K · filed 2026-03-17 | ||||||
| 2023-12-31 | -6.20M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | -1.73M shares derived: average of 2 quarters · filed 2026-09-11 | -412.69K shares derived: average of 3 quarters · filed 2026-09-11 | 233.67K shares S-1 · filed 2026-09-11 | 2.57M shares 10-K · filed 2026-03-17 | |||
| 2023-09-30 | 2.75M shares 10-Q · filed 2023-11-13 | 2.48M shares derived: average of 2 quarters · filed 2023-11-13 | 2.38M shares 10-Q · filed 2023-11-13 | 2.32M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2023-06-30 | 2.21M shares 10-Q · filed 2023-08-11 | 2.19M shares 10-Q · filed 2023-08-11 | 2.18M shares derived: average of 3 quarters · filed 2023-08-11 | 2.18M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2023-03-31 | 2.17M shares 10-Q · filed 2023-05-12 | 2.17M shares derived: average of 2 quarters · filed 2023-05-12 | 2.17M shares derived: average of 3 quarters · filed 2023-11-13 | 2.17M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-12-31 | 2.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 2.17M shares derived: average of 2 quarters · filed 2023-11-13 | 2.17M shares derived: average of 3 quarters · filed 2023-11-13 | 2.17M shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 2.17M shares 10-Q · filed 2023-11-13 | 86.66M shares 10-Q · filed 2022-11-10 | 2.17M shares derived: average of 2 quarters · filed 2023-11-13 | 2.17M shares 10-Q · filed 2023-11-13 | 86.65M shares 10-Q · filed 2022-11-10 | -44.95M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 2.17M shares 10-Q · filed 2023-08-11 | 86.65M shares 10-Q · filed 2022-08-12 | 2.17M shares 10-Q · filed 2023-08-11 | 86.65M shares 10-Q · filed 2022-08-12 | -60.65M shares derived: average of 3 quarters · filed 2023-08-11 | -23.94M shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 2.17M shares 10-Q · filed 2023-05-12 | -92.06M shares derived: average of 2 quarters · filed 2023-05-12 | -32.64M shares derived: average of 3 quarters · filed 2023-05-12 | -7.88M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -186.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -50.04M shares derived: average of 2 quarters · filed 2023-03-31 | -11.23M shares derived: average of 3 quarters · filed 2023-03-31 | 1.75M shares 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | 86.21M shares 10-Q · filed 2022-11-10 | 76.30M shares derived: average of 2 quarters · filed 2022-11-10 | 64.43M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 66.39M shares 10-Q · filed 2022-08-12 | 53.36M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |